Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Shock ; 29(1): 133-9, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18246604

RESUMO

Clinical studies indicate potential differences in the efficacy of immunoglobulin (Ig) preparations in patients with sepsis. A recent meta-analysis showed improved survival rates with IgM-enriched Igs. It was the objective of the present study to characterize microcirculatory actions of different clinically used Ig preparations in a rodent endotoxin model by intravital microscopy. Male Syrian golden hamsters 6 to 8 weeks old with a body weight of 60 to 80 g were investigated by intravital fluorescence microscopy. Endotoxemia was induced by administration of 2 mg/kg (i.v.) endotoxin (LPS, Escherichia coli). Two different Ig preparations containing IgM, IgA, and IgG (intravenous IgM group; n = 6; 5 mL Pentaglobin/kg body weight, i.v.) or exclusively IgG (intravenous IgG group; n = 5; 5 mL Flebogamma/kg body weight, i.v.) were applied 5 min before LPS. Saline-treated endotoxemic animals served as controls (control; n = 8). In controls, LPS induced massive leukocyte-endothelial cell interactions, pronounced microvascular leakage, a decrease of systemic platelet count, and distinct capillary perfusion failure (P < 0.05). Both intravenous IgM and IgG reduced venular leakage (P< 0.05) and ameliorated the decrease in platelet count (P < 0.05). Of interest, intravenous IgM was capable of significantly (P< 0.05) reducing leukocyte adhesion in venules. This was associated with normalization of capillary perfusion at 24 h of endotoxemia, whereas intravenous IgG could not prevent LPS-mediated microvascular perfusion failure. We demonstrate that IgM-enriched Igs are superior to IgG alone in attenuating LPS-induced leukocytic inflammation and microcirculatory dysfunction. Our findings can explain better efficacy of IgM-enriched Igs in patients with severe sepsis.


Assuntos
Endotoxemia/terapia , Imunoglobulina M/uso terapêutico , Imunoglobulinas Intravenosas/uso terapêutico , Animais , Adesão Celular/efeitos dos fármacos , Cricetinae , Modelos Animais de Doenças , Células Endoteliais/efeitos dos fármacos , Células Endoteliais/fisiologia , Endotoxemia/patologia , Endotoxemia/fisiopatologia , Humanos , Imunoglobulina G/administração & dosagem , Imunoglobulina G/uso terapêutico , Imunoglobulina M/administração & dosagem , Migração e Rolagem de Leucócitos/efeitos dos fármacos , Leucócitos/efeitos dos fármacos , Leucócitos/fisiologia , Lipopolissacarídeos/toxicidade , Masculino , Mesocricetus , Microcirculação/efeitos dos fármacos , Microcirculação/patologia , Microcirculação/fisiopatologia , Microscopia de Fluorescência , Sepse/patologia , Sepse/fisiopatologia , Sepse/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...